'Considerable disagreement' between quantitative sonography and DXA for diagnosing osteoporosis

September 01, 2004

A lack of correlation between quantitative sonography and dual-energy X-ray absorptiometry (DXA) in detecting osteoporosis makes quantitative sonography impractical for routine diagnostic use, despite it being able to evaluate bone fracture risk without the use of ionizing radiation, say researchers from the University of Vienna in Austria.

Both quantitative sonography and DXA are imaging methods used to measure bone density and quality, with the former using sound waves and the latter X-rays. Currently, DXA is the gold standard for detecting osteoporosis. For the study, the researchers took DXA measurements of the lower spine and thigh and quantitative sonography measurements of the forearm in 121 patients. Thirty-one percent of the patients were diagnosed as osteoporotic after DXA of the spine and 43% after DXA of the thigh, whereas 34% were diagnosed as osteoporotic after quantitative sonography of the forearm. According to the study, the correlation between the two methods is categorized as only "fair to moderate" and lower than the threshold level needed for practical diagnostic use.

"If the correlation between quantitative sonography and DXA measurements were better, quantitative sonography would have the advantage to replace DXA measurements in individuals suspected of having osteoporosis," said Christian R. Krestan, MD, lead author of the study. "Our study demonstrates only limited correlation. However, for practical reasons further studies should be carried out with quantitative ultrasound devices," he added.
-end-
The article appears in the September 2004 issue of the American Journal of Roentgenology.

American College of Radiology

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.